Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you searched for a GLP-1 protein calculator, you already know the hardest part of GLP-1 weight loss: appetite is suppressed, and the protein you need to preserve muscle is the first macronutrient that quietly disappears from your plate. Published clinical guidance for patients on semaglutide and tirzepatide centers around 1.0–1.5 grams of protein per kilogram of body weight per day during active weight loss — meaningfully higher than the 0.8 g/kg RDA written for sedentary adults at weight maintenance. This article gives you the math, the per-meal distribution, the food list that actually goes down on a nausea day, and where the PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol sit relative to those targets — because protein arithmetic only matters if it survives the first month of titration.

How to calculate your daily GLP-1 protein target

The protein target on a GLP-1 is set in grams per kilogram of current body weight per day. The clinical-recommendation band is 1.0–1.5 g/kg/day, with the 1.4–1.6 g/kg upper end reserved for patients who are strength training, losing weight quickly, or older than 60. Convert pounds to kilograms by dividing by 2.2, then multiply by your chosen target. A 180 lb patient (82 kg) at the 1.4 g/kg midpoint lands at roughly 115 g/day; the same patient at 1.0 g/kg sits at 82 g/day; at 1.6 g/kg, 131 g/day. Use current weight, not goal weight — using goal weight from week one almost always under-doses the protein required to protect lean mass while you are still actively losing. Recalculate every 10–15 lb of loss; the g/kg ratio stays the same, but the absolute grams should fall as you do.

Quick-reference protein targets by weight

If you don't want to do the arithmetic, the table below covers common cash-pay GLP-1 weights at 1.2 g/kg (low end), 1.4 g/kg (clinical midpoint), and 1.6 g/kg (high end for strength training or rapid loss). These are the same brackets clinicians use when titrating compounded semaglutide on the PlexusDx Semaglutide Injection protocol or compounded tirzepatide on the Tirzepatide Injection protocol. At 150 lb (68 kg): 80 g, 95 g, 110 g. At 175 lb (79 kg): 95 g, 110 g, 125 g. At 200 lb (91 kg): 110 g, 125 g, 145 g. At 225 lb (102 kg): 120 g, 145 g, 165 g. At 250 lb (113 kg): 135 g, 160 g, 180 g. At 275 lb (125 kg): 150 g, 175 g, 200 g. At 300 lb (136 kg): 165 g, 190 g, 220 g. The midpoint column (1.4 g/kg) is the default starting point for most patients in active GLP-1-driven weight loss.

Why protein matters more on GLP-1 medications

Every weight-loss method pulls a mix of fat and lean tissue off the body. The published lean-mass-loss share during GLP-1-driven weight loss runs 25–40% of total weight lost in some analyses — the same range as caloric-restriction-only studies, but harder to push down because appetite suppression is doing the work that food discipline used to do. Two levers move that ratio: protein intake and resistance training. Adequate protein (1.2–1.6 g/kg/day) plus 2–3 sessions per week of resistance training is the published combination that protects lean mass during semaglutide and tirzepatide therapy. Skipping either lever — or undereating across the board because food just isn't appealing — is how patients end up at goal weight with a noticeably weaker, slower-resting-metabolism body. The PlexusDx Microdose GLP-1 Protocol at $129/mo flat is often used by patients who want a slower titration specifically to make protein discipline easier in the early weeks.

How to actually hit your protein target on GLP-1s

Knowing the number is the easy part. Eating 110–160 grams of protein on a day when nausea hits at 11 a.m. is the hard part. Four practices reliably move the needle. First, protein first, every meal — eat the protein portion of a meal before bread, rice, vegetables, or fat, so when satiety arrives early at least the highest-leverage macronutrient is in. Second, front-load the day — appetite is highest in the morning for most GLP-1 patients, so 30–40% of daily protein in the first meal is a reliable strategy. Third, keep liquid protein on standby — whey or casein shakes, Greek yogurt drinks, fairlife-style high-protein milk, and drinkable cottage cheese all go down on days solid food does not. Fourth, pick three to four anchor foods you can eat reliably and rotate them: most patients land on Greek yogurt, eggs, deli turkey or chicken breast, and cottage cheese as the bedrock.

High-protein foods and per-meal distribution

Practical pickings ranked by tolerability when appetite is low: plain 0% Greek yogurt (23 g per cup), low-fat cottage cheese (28 g per cup), grilled chicken breast (31 g per 4 oz), two whole eggs (12 g), one cup egg whites (26 g), 4 oz turkey deli meat (22 g), 4 oz canned tuna in water (22 g), 4 oz baked salmon (25 g), 4 oz cooked shrimp (24 g), 4 oz 93% lean ground beef (24 g), half a block of extra-firm tofu (21 g), and one scoop of whey protein powder (25 g). The body uses protein most efficiently in 25–40 g doses per meal for muscle protein synthesis. If your daily target is 120 g and you eat four times, aim for ~30 g per meal. Front-loading is the practical adjustment for GLP-1 patients: 35–40 g at breakfast, 35–40 g at lunch, 25–30 g at dinner, and a 15–20 g snack. A nausea-day floor of 75–95 g (chilled shake at breakfast, deli turkey and a cheese stick at midday, cottage cheese in the afternoon, cold chicken or light fish in the evening) is acceptable as a recovery-day pattern.

Genetics, dose, and protein — why one number does not fit everyone

The 1.0–1.5 g/kg/day band is a population midpoint. Individual response to GLP-1 medications varies meaningfully — variants in GLP1R (the GLP-1 receptor itself), GIPR (which matters specifically for tirzepatide's dual-agonist mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with different weight-loss curves and different tolerability profiles. The Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month on any PlexusDx protocol) maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so the prescribing clinician knows whether a faster titration, a slower one, or a tirzepatide-first approach better fits your biology. Patients who are losing rapidly or who carry a fast-titration genetic profile usually sit at the 1.4–1.6 g/kg/day end of the protein band; slower responders often do well at 1.2 g/kg with disciplined resistance training. The protein number should track the dose path, not the other way around.

Special situations: diabetes, age 60+, plant-based, and strength training

Type 2 diabetes patients on a GLP-1 generally use the same 1.0–1.5 g/kg/day band, with the caveat that protein at breakfast can blunt morning glucose spikes — so front-loading has a second benefit beyond muscle preservation. Patients over 60 should anchor at the 1.2–1.6 g/kg end, because age-related anabolic resistance means a higher per-meal dose is required to trigger the same muscle protein synthesis response. Vegetarians and vegans need to be intentional about leucine content — soy, pea-rice blends, seitan, tempeh, and Greek yogurt or cottage cheese (lacto-ovo) all work; combining 35–40 g plant protein with a leucine-rich source per meal is the published strategy. Patients training 2+ resistance sessions per week should default to the 1.4–1.6 g/kg upper end. None of these adjustments are large — 0.2–0.4 g/kg shifts inside the same band — but they are the difference between protecting lean mass and losing it. The PlexusDx GLP-Squared dual-compound stack ($249/mo), used for advanced or escalation cases, sits in the same upper-end protein logic.

Frequently asked questions

How much protein should I eat on Ozempic or Wegovy?

The published clinical band is 1.0–1.5 grams of protein per kilogram of body weight per day during active GLP-1-driven weight loss. For a 180 lb (82 kg) patient that is roughly 82–122 g/day; for a 200 lb (91 kg) patient, 91–137 g/day. Anchor at the 1.4 g/kg midpoint unless you are strength training (push to 1.6 g/kg) or a slower responder (1.2 g/kg with resistance training is fine).

What if I can't hit my protein target?

Hitting 80% of the target is meaningfully better than abandoning it. Use protein-first eating, keep chilled protein shakes and Greek yogurt as backup, and accept a 75–95 g nausea-day pattern as a recovery floor. The PlexusDx Microdose GLP-1 Protocol at $129/mo is sometimes selected specifically for slower titration so protein discipline is easier in the early weeks.

Are protein shakes okay on GLP-1 medications?

Yes. Look for at least 20–30 g protein per serving, under 5 g added sugar, and whey, casein, or pea-rice blend as the primary protein. Cold, blended shakes go down better than warm or thick ones on nausea days. Shakes are a backup tool, not a replacement for whole-food protein over a full week.

How should I split protein across meals?

Distribute evenly across three to five eating occasions, targeting 25–40 g per meal. For a 120 g/day target across four meals, ~30 g each works. Front-load when appetite is highest (often morning for GLP-1 patients): 35–40 g at breakfast and lunch, 25–30 g at dinner, and a 15–20 g snack.

Should I use my current weight or goal weight to calculate protein?

Always current weight. Using goal weight from day one under-doses protein during the period when lean-mass preservation matters most. Recalculate every 10–15 lb of loss — the g/kg ratio stays constant, but absolute grams will drop as you do.

Does the PlexusDx protocol I choose change my protein target?

The g/kg band does not change by molecule, but the rate of loss often does — tirzepatide on the Tirzepatide Injection protocol typically drives faster early loss than semaglutide on the Semaglutide Injection protocol. Faster loss raises the case for the 1.4–1.6 g/kg upper end and 2–3 weekly resistance sessions.

Can too much protein hurt my kidneys?

For people with healthy kidneys, intakes up to 2.0 g/kg/day have not been shown to cause damage in clinical research. If you have existing chronic kidney disease, your nephrologist may recommend a different ceiling — bring the question to them before increasing intake. The 1.0–1.5 g/kg/day GLP-1 band is well below the level associated with concern in healthy individuals.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing referenced for any third-party brand is based on each provider's published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

learn